These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8344004)

  • 21. Phenyl di-n-pentylphosphinate: a convenient reactivatible inhibitor for studies on neuropathy target esterase (NTE) and protection against organophosphate-induced delayed polyneuropathy.
    Johnson MK; Bird I; Meredith C
    Toxicol Lett; 1988 Feb; 40(2):133-40. PubMed ID: 2829392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuropathy target esterase inhibition by organophosphorus esters in human neuroblastoma cells.
    Ehrich M; Correll L; Veronesi B
    Neurotoxicology; 1994; 15(2):309-13. PubMed ID: 7991219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Species susceptibility to delayed toxic neuropathy in relation to in vivo inhibition of neurotoxic esterase by neurotoxic organophosphorus esters.
    Soliman SA; Linder R; Farmer J; Curley A
    J Toxicol Environ Health; 1982 Feb; 9(2):189-97. PubMed ID: 7077681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A mechanism for organophosphate-induced delayed neuropathy.
    Glynn P
    Toxicol Lett; 2006 Mar; 162(1):94-7. PubMed ID: 16309859
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The R-(+)isomer of O-n-hexyl S-methyl phosphorothioamidate causes delayed neuropathy in hens after generation of a form of inhibited neuropathy target esterase (NTE) which can be reactivated ex vivo.
    Johnson MK; Safi JM
    Chem Biol Interact; 1993 Jun; 87(1-3):443-8. PubMed ID: 8344001
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurotoxic esterase in rooster testis.
    Lotti M; Wei ET; Spear RC; Becker CE
    Toxicol Appl Pharmacol; 1985 Jan; 77(1):175-80. PubMed ID: 3966239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Actions of two highly potent organophosphorus neuropathy target esterase inhibitors in mammalian cell lines.
    Li W; Casida JE
    Toxicol Lett; 1997 Jul; 92(2):123-30. PubMed ID: 9295235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Organophosphate induced delayed polyneuropathy.
    Jokanovic M; Stukalov PV; Kosanovic M
    Curr Drug Targets CNS Neurol Disord; 2002 Dec; 1(6):593-602. PubMed ID: 12769600
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence that mouse brain neuropathy target esterase is a lysophospholipase.
    Quistad GB; Barlow C; Winrow CJ; Sparks SE; Casida JE
    Proc Natl Acad Sci U S A; 2003 Jun; 100(13):7983-7. PubMed ID: 12805562
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuropathy target esterase in hens after sarin and soman.
    Crowell JA; Parker RM; Bucci TJ; Dacre JC
    J Biochem Toxicol; 1989; 4(1):15-20. PubMed ID: 2769693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative studies of O,O-dialkyl-O-chloromethylchloroformimino phosphates: interaction with neuropathy target esterase and acetylcholinesterase.
    Makhaeva GF; Filonenko IV; Yankovskaya VL; Fomicheva SB; Malygin VV
    Neurotoxicology; 1998; 19(4-5):623-8. PubMed ID: 9745921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prophylaxis and the mechanism for the initiation of organophosphorous compound-induced delayed neurotoxicity.
    Carrington CD
    Arch Toxicol; 1989; 63(3):165-72. PubMed ID: 2669680
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Promoters and promotion of axonopathies.
    Moretto A
    Toxicol Lett; 2000 Mar; 112-113():17-21. PubMed ID: 10720708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Promotion of peripheral axonopathies by certain esterase inhibitors.
    Moretto A; Lotti M
    Toxicol Ind Health; 1993; 9(6):1037-46. PubMed ID: 8191502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The pathogenesis of organophosphate polyneuropathy.
    Lotti M
    Crit Rev Toxicol; 1991; 21(6):465-87. PubMed ID: 1666291
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An alternative in vitro method for detecting neuropathic compounds based on acetylcholinesterase inhibition and on inhibition and aging of neuropathy target esterase (NTE).
    Sogorb MA; González-González I; Pamies D; Vilanova E
    Toxicol In Vitro; 2010 Apr; 24(3):942-52. PubMed ID: 20097283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of beta-naphthoflavone on o-tolyl saligenin phosphate-induced delayed neuropathy in two lines of chickens.
    Bursian SJ; Lehning EJ; Correll L; Ehrich M
    J Toxicol Environ Health; 1989; 28(4):461-71. PubMed ID: 2593176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interactions of neuropathy inducers and potentiators/promoters with soluble esterases.
    Estévez J; Mangas I; Sogorb MÁ; Vilanova E
    Chem Biol Interact; 2013 Mar; 203(1):245-50. PubMed ID: 23200747
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biochemical endpoints: neurotoxic esterase assay.
    Johnson MK; Richardson RJ
    Neurotoxicology; 1983; 4(2):311-20. PubMed ID: 6685269
    [No Abstract]   [Full Text] [Related]  

  • 40. Using neuroblastoma cell lines to address differential specificity to organophosphates.
    Ehrich M
    Clin Exp Pharmacol Physiol; 1995 Apr; 22(4):291-2. PubMed ID: 7671443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.